Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
177Lu-PSMA-VG01
- Development stage
- Phase 1
- Lead developer
- VitsGen Therapeutics
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals, Small Molecules
- Administration
- Intravenous
01
Overview
177Lu-PSMA-VG01 is a therapeutic radiopharmaceutical consisting of the beta-emitting radioisotope lutetium-177 conjugated to a ligand targeting prostate-specific membrane antigen (PSMA). Developed by Shandong V-Zhi Zhike Pharmaceutical, the agent is designed to treat PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). By binding to PSMA, which is overexpressed on prostate cancer cells, the drug delivers localized ionizing radiation that induces DNA damage and cell death. It is currently undergoing Phase 1 clinical evaluation for safety, dosimetry, and preliminary efficacy in patients previously treated with androgen receptor pathway inhibitors and taxanes.
- Other names
- [177Lu]Lu-PSMA-VG01
02
Targets
PSMA (Prostate-specific membrane antigen)
Beyond the preview
Go deeper on 177Lu-PSMA-VG01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 177Lu-PSMA-VG01.